Dermal drug delivery with ethosomes: Therapeutic potential

Therapy

Volumn 4, Issue 4, 2007, Pages 465-472

  Touitou, Elka ^a   Godin, Biana ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Acne vulgaris; Antibiotics; Antivirals; Cannabinoids; Deep skin infections; Dermatological agents; Ethosomes; HSV 1; Inflammation

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACITRACIN; BENZOYL PEROXIDE; CANNABIDIOL; CLINDAMYCIN; DRUG CARRIER; ERYTHROMYCIN; ETHOSOME; KETOTIFEN; LIPOSOME; MINOXIDIL; PLACEBO; PROSTAGLANDIN E1; STEROID; TACROLIMUS; UNCLASSIFIED DRUG;

ACNE VULGARIS; ATOPIC DERMATITIS; BACTERIAL SKIN DISEASE; BURNING SENSATION; CLINICAL TRIAL; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG TOLERABILITY; ENCAPSULATION; ERECTILE DYSFUNCTION; ERYTHEMA; HERPES LABIALIS; HUMAN; IMMUNE DEFICIENCY; INFLAMMATION; MALE TYPE ALOPECIA; NONHUMAN; PHOTOSENSITIVITY; PHYSICAL CHEMISTRY; PRURITUS; REVIEW; RHEUMATOID ARTHRITIS; SKIN ABSORPTION; SKIN PENETRATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 34447580947     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.2217/14750708.4.4.465     Document Type: Review

References (28)

1. Schaefer H. Redelmeier TE: Skin Barrier - Principles of Percutaneous Absorption. Karger AG, Basel, Switzerland (1996).
2. Schreiner V, Gooris GS, Pfeiffer S et al.: Barrier characteristics of different human skin types investigated with x-ray diffraction, lipid analysis, and electron microscopy imaging. J. Invest. Dermatol. 114(4), 654-660 (2000).
3. Wertz PW: Lipids and barrier function of the skin. Acta Derm. Venereol. 208 (Suppl.). 7-11 (2000).
4. Norlen L: Skin barrier structure and function: the single gel phase model. J. Invest. Dermatol. 117, 830-836 (2001).
5. Holleran WM, Takagi Y, Uchida Y: Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett. 580(23), 5456-5466 (2006).
6. Bouwstra J, Pilgram G, Gooris G et al.: New aspects of the skin barrier organization. Skin Pharmacol. Appl. Skin Physiol. 14, 52-62 (2001).
7. Hadgraft J: Skin, the final frontier. Int. J. Pharm. 14, 1-18 (2001).
8. Toultou E: Drug delivery across the skin. Expert Opin. Biol. Ther. 2, 723-733 (2002).
9. Touitou E, Dayan N, Bergelson L et al.: Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control. Release 65, 403-418 (2000).
10. Godin B, Touitou E: Erythromycin ethosomal systems: physicochemical characterization and enhanced antibacterial activity. Curr Drug Deliv. 2, 269-275 (2005).
11. Dayan N, Touitou E: Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 21, 1879-1885 (2000).
12. Godin B, Touitou E: Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J. Control. Release 94, 365-379 (2004).
13. Touitou E, Godin B: New approaches for UV-induiced photodamage protection. J. Appl. Cosm. 24, 139-147 (2006).
14. Godin B, Alcabez M. Touitou E: Minoxidil and erythromycin targeted to pilosebaceous units by ethosomal delivery systems. Acta Technol. Legis Medicament 10, 107 (1999).
15. Touitou E, Godin B, Dayan N et al.: Intracellular delivery mediated by an ethosomal carrier. Biomaterials 22, 3053-3059 (2001).
16. Paolino D, Lucania G, Mardente D et al.: Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J. Control. Release 106(1-2), 99-110 (2005).
17. Horwitz E, Pisanty S, Czerninsky R et al.: A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 88, 700-705 (1999).
18. Shaw M, King M, Best JM et al.: Failure of acyclovir cream in the treatment of recurrent herpes labialis. Br Med. J. 291, 7-9 (1985).
19. Touitou E, Godin B, Shumilov M et al.: Efficacy and tolerability of clindamycin phosphate and salicyclic acid gel in the treatment of mild to moderate acne vulgaris. J. Eur. Acad. Dermatol. Venerol. (2007) (In Press
20. Leyden JJ, Shalita AR, Saatjian GD et al.: Erythromycin 2% gel in comparison with clindamycin phosphate 1% solution in acne vulgaris. J. Am. Acad. Darmatol. 16, 822-827 (1987).
21. Lookingbin DP, Chalker DK, Lindholm JS et al.: Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J. Am. Acad. Dermatol. 37, 590-595 (1997).
22. Nichols RL: Optimal treatment of complicated skin and skin structure infections. J. Antimicrob. Chemother. 44, 19-23 (1999).
23. Godin B, Touitou E, Rubinstein E et al.: A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study. J. Antimicrob. Chemother. 55, 989-994 (2005).
24. Lodzki M, Godin B, Rakou L et al.: Cannabidol - transdermal delivery and anti-inflammatory effect in a murine model. J. Control. Release 93, 377-387 (2003).
25. Elsayed MM. Abdallah OY, Naggar VF et al.: Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen Pharmazie 62, 133-137 (2007).
26. Godin B, Toultou E: Ethosomes: new prospects in transdermal delivery. Crit. Rev. Ther. Drug Carrier Sys. 20, 63-102 (2003).
27. Touitou E, Godin B, Weiss C: Enhanced delivery of drugs into and across the skin by ethosomal carriers. Drug Dev. Res. 50, 406-415 (2000).
28. Touitou E, Godin B: Vesicles for enhanced delivery into and through the skin. In: Enhancement in Drug Delivery. Touitou E, Barry BW (Eds). CRC Press, Taylor & Francis Group, London, UK 255-278 (2006).